Association of an apolipoprotein B gene marker with essential hypertension

Hypertension

Volumn 33, Issue 4, 1999, Pages 1052-1056

  Frossard, Philippe M ^a,d   Obineche, Enyioma N ^b   Lestringant, Gilles G ^c  

^a Department of Pathology ^*  (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c TAWAM HOSPITAL   (United Arab Emirates)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Apolipoproteins B; Case control studies; Genetics; Hypertension, essential; Repetitive sequences, nucleic acid; United Arab Emirates

Indexed keywords

APOLIPOPROTEIN B; DNA; REPETITIVE DNA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; UNITED ARAB EMIRATES;

EID: 0032942483     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.4.1052     Document Type: Article

References (31)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990: 81-100.
2. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci U S A. 1995;92:8545-8551.
3. Soubrier F, Lathrop GM. The genetic basis of hypertension. Curr Opin Nephrol Hypenens. 1995;4:177-181.
4. Humphries SE, Dunning A, Xu CF, Peacock R, Talmud P, Hamsten A. DNA polymorphism studies: approaches to elucidating multifactorial ischemic heart disease: the apo B gene as an example. Ann Med. 1992; 24:349-356.
5. Knott TJ, Wallis SC, Pease RJ, Powell LM, Scott J. A hypervariable region 3′ to the human apolipoprotein B gene. Nucleic Acids Res. 1986; 14:9215-9216.
6. Boerwinkle E, Xiong W, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci U S A. 1989;86:212-216.
7. Vedie B, Myara I, Jeunemaitre X, Moatti N. Genetic variations in the apolipoprotein B gene (in French). Ann Génét. 1995;38:187-201.
8. Ye P, Chen B, Wang S. The association of polymorphisms at a VNTR locus 3′ to the apolipoprotein B gene with coronary heart disease in Chinese population. Chinese Med Sci J. 1995;10:63-69.
9. Wu JH, Chem MS, Lo SK, Wen MS, Kao JT. Apolipoprotein B 3′ hypervariable repeat genotype: association with plasma lipid concentration, coronary artery disease, and other restriction fragment polymorphisms. Clin Chem. 1996;42:927-932.
10. Higashimori K, Higaki J, Miki T, Kamitani A., Mikami H, Kumahara Y, Ogihara T. Analysis of the apolipoprotein B3′ hypervariable region in patients with essential hypertension. Clin Exp Pharmacol Physiol. 1992; 19(suppl 20):21-23.
11. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
12. Lander ES. The new genomics: global views of biology. Science. 1996; 274:536-539.
13. Schork N. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension. 1997;29(pt 2):145-149.
14. Frossard PM, Obineche EN, Elshahat YI, Lestringant GG. Deletion polymorphism in the angiotensin-converting enzyme gene is not associated with hypertension in a Gulf Arab population. Clin Genet. 1997;50: 211-213.
15. Latorra D, Stern CM, Schanfield MS. Characterization of human AFLP systems apolipoprotein B, phenylalanine hydroxylase, and D1S80. PCR Methods Appl. 1994;3:351-358.
16. Nei M. Molecular evolutionary genetics. Columbia University Press; New York, NY: 1987.
17. Alavantic D, Glisic S, Erceg S, Stupar M. Genetic variation at the apoB 3' hypervariable region in a Serbian population. Eur J Hum Genet. 1997;5:333-335.
18. Hegele RA, Breslow JL. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility. Genet Epidemiol. 1987;4: 163-184.
19. Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F. Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis. 1990;10:17-24.
20. Hegele RA, Huang L, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. New Engl J Med. 1986;315:1509-1515.
21. Friedl W, Ludwig EH, Paulweber B, Sandhofer F, McCarthy BJ. Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J Lipid Res. 1990;31:659-665.
22. Tybjærg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE. Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis. 1991;89: 69-81.
23. Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG. Molecular genetics of apolipoprotein and coronary heart disease. Cold Spring Harb Symp Quant Biol. 1986;51(pt 1):403-409.
24. Tikkanen MJ, Heliö T. Genetic variants of apolipoprotein B: relation to serum lipid levels and coronary artery disease among the Finns. Ann Med. 1992;24:357-361.
25. Turner PR, Talmud PJ, Visvikis S, Ehnholm C, Tiret L. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis. 1995;116:221-234.
26. Tybjærg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med. 1998;338:1577-1584.
27. Bonaa KH, Thelle DS. Association between blood pressure and serum lipids in a population: the Tromso Study. Circulation. 1991;83: 1305-1314.
28. Kistler T, Weisser B. Correlation between disorders of lipid metabolism and hypertension in 10,892 participants in the Heureka Study [in German]. Schweiz Rundsch Med Prax. 1993;82:1222-1233.
29. Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, Barlow GK, Schumacher MC, Ludwig EH. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens. 1993;6(pt 2):319S-327S.
30. Caulfield M, Bouloux PM, Munroe P. Progress in determining the genes for hypertension, insulin resistance, and dyslipidemia. Ann N Y Acad Sci. 1997;827:110-117.
31. Re RN, Frohlich ED. Controversies in the genetic analysis of hypertensive diseases. Hypertension. 1996;28:880. Editorial.